High-dose helical tomotherapy with concurrent full-dose chemotherapy for locally advanced pancreatic cancer

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 5, 2012, Pages 1448-1454

  Chang, Jee Suk ^a   Wang, Michael L C ^c   Koom, Woong Sub ^a   Yoon, Hong In ^a   Chung, Yoonsun ^a   Song, Si Young ^b   Seong, Jinsil ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

Helical tomotherapy; Locally advanced pancreatic cancer; Patterns of failure; Radiotherapy

Indexed keywords

CHEMOTHERAPY; CONCURRENCY CONTROL; DISEASES; RADIOTHERAPY; TOXICITY;

GASTROINTESTINAL TOXICITIES; HELICAL TOMOTHERAPY; LOCALLY ADVANCED PANCREATIC CANCERS; METHODS AND MATERIALS; PATTERNS OF FAILURE; PROGRESSION FREE SURVIVAL; PROGRESSION FREE SURVIVAL RATES; THERAPEUTIC OUTCOMES;

CHEMORADIOTHERAPY;

CISPLATIN; CONTRAST MEDIUM; DIATRIZOATE; GEMCITABINE; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR;

ABDOMINAL DISTENSION; ADULT; ADVANCED CANCER; AGED; ANEMIA; CHEMORADIOTHERAPY; CLINICAL ARTICLE; DEATH; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL OBSTRUCTION; HUMAN; LEUKOPENIA; MALE; NAUSEA AND VOMITING; OVERALL SURVIVAL; PANCREAS CANCER; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; REVIEW; SIMULTANEOUS INTEGRATED BOOST HELICAL TOMOTHERAPY; THROMBOCYTOPENIA; TOMOTHERAPY; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE; VOMITING;

EID: 84863608085     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.10.050     Document Type: Article

References (19)

1. C.G. Moertel, S. Frytak, and R.G. Hahn Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group Cancer 48 1981 1705 1710
2. S.M. de Lange, C.J. van Groeningen, and O.W. Meijer Gemcitabine- radiotherapy in patients with locally advanced pancreatic cancer Eur J Cancer 38 2002 1212 1217
3. C.P. Li, Y. Chao, and K.H. Chi Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: Gemcitabine versus 5-fluorouracil, a randomized controlled study Int J Radiat Oncol Biol Phys 57 2003 98 104
4. R. Epelbaum, E. Rosenblatt, and S. Nasrallah Phase II study of gemcitabine combined with radiation therapy in patients with localized, unresectable pancreatic cancer J Surg Oncol 81 2002 138 143
5. J.D. Murphy, S. Adusumilli, and K.A. Griffith Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer Int J Radiat Oncol Biol Phys 68 2007 801 808
6. M. Mohiuddin, W.F. Regine, and J. Stevens Combined intraoperative radiation and perioperative chemotherapy for unresectable cancers of the pancreas J Clin Oncol 13 1995 2764 2768
7. S. Yovino, M. Poppe, and S. Jabbour Intensity-modulated radiation therapy significantly improves acute gastrointestinal toxicity in pancreatic and ampullary cancers Int J Radiat Oncol Biol Phys 79 2011 158 162
8. M.P. Callery, K.J. Chang, and E.K. Fishman Pretreatment assessment of resectable and borderline resectable pancreatic cancer: Expert consensus statement Ann Surg Oncol 16 2009 1727 1733
9. H.M. Kim, S. Bang, and J.Y. Park Phase II trial of S-1 and concurrent radiotherapy in patients with locally advanced pancreatic cancer Cancer Chemother Pharmacol 63 2009 535 541
10. S. Bang, T.J. Jeon, and M.H. Kim Phase II study of cisplatin combined with weekly gemcitabine in the treatment of patients with metastatic pancreatic carcinoma Pancreatology 6 2006 635 641
11. P. Therasse, S.G. Arbuck, and E.A. Eisenhauer New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 2000 205 216
12. C.G. Willett, B.G. Czito, and J.C. Bendell Locally advanced pancreatic cancer J Clin Oncol 23 2005 4538 4544
13. F. Rivera, S. Lopez-Tarruella, and M.E. Vega-Villegas Treatment of advanced pancreatic cancer: From gemcitabine single agent to combinations and targeted therapy Cancer Treat Rev 35 2009 335 339
14. R.A. Wolff, D.B. Evans, and D.M. Gravel Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma Clin Cancer Res 7 2001 2246 2253
15. C.J. McGinn, M.M. Zalupski, and I. Shureiqi Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer J Clin Oncol 19 2001 4202 4208
16. C.H. Crane, J.A. Antolak, and Rosen II Phase I study of concomitant gemcitabine and IMRT for patients with unresectable adenocarcinoma of the pancreatic head Int J Gastrointest Cancer 30 2001 123 132
17. E. Ben-Josef, K.A. Griffith, and I.R. Francis Phase I radiation dose-escalation trial of intensity-modulated radiotherapy (IMRT) with concurrent fixed dose-rate gemcitabine (FDR-G) for unresectable pancreatic cancer [abstract] J Clin Oncol 27 2009 4602a
18. A.W. Blackstock, J.E. Tepper, and D. Niedwiecki Cancer and leukemia group B (CALGB) 89805: Phase II chemoradiation trial using gemcitabine in patients with locoregional adenocarcinoma of the pancreas Int J Gastrointest Cancer 34 2003 107 116
19. Z. Symon, T. Rabin, and D. Levin Tolerability of standard fractionation vs. hypofractionation in chemoradiotherapy of pancreatic cancer [abstract] Int J Radiat Oncol Biol Phys 66 2006 S284 S285